Insiders Acelyrin, Inc.

Equities

SLRN

US00445A1007

Real-time Estimate Cboe BZX Other stock markets 10:24:09 2024-06-04 EDT			5-day change	1st Jan Change
4.155 ^USD	+1.34%		+2.35%	-44.44%

05-22	HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating	MT
05-14	Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024	05-09	CI
Acelyrin, Inc. Announces CEO Changes	05-09	CI
Acelyrin, Inc. Announces Leadership Transition	05-09	CI
Madrigal Pharmaceuticals Names New CFO	02-28	MT
Acelyrin, Inc. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications	02-15	CI
Acelyrin, Inc. Appoints Lynn Tetrault to Board of Directors	12-20	CI
Acelyrin, Inc. Appoints Patricia Turney as Chief Technical Operations Officer	11-06	CI
Acelyrin, Inc. Appoints Shephard Mpofu as Senior Vice President of Development	23-10-03	CI
Acelyrin, Inc. Appoints Gil Labrucherie as Full Time Chief Financial Officer	23-08-21	CI
Acelyrin, Inc. Announces Resignation of Mardi C. Dier as Chief Financial Officer Effective August 15, 2023	23-08-02	CI
Acelyrin, Inc. Announces Resignation of Mardi C. Dier as Chief Business Officer Effective August 15, 2023	23-08-02	CI
ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer	23-07-18	CI
Insider Buy: Acelyrin	23-05-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer